Very positive Ann. I am in now: Sold out my MSB and bought almost 7 times more CYP. Less risk I think because if MSB trial is “successful”, then CYP will rise too on stem cell association. If MSB results are not good or hijacked by USA then high risk of MSB sp fall but less relevance to CYP plans or effect on sp.
My risk averse opinion only, dyor.
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial, page-119
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $40.65M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 69 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 49931 | 1 |
View Market Depth
| Last trade - 07.02am 17/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable